Cargando…

A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression

Objective: C49 is a chalcone derivative. The aim of the current study is to illuminate the efficacy of C49 in reversing multidrug resistance (MDR) in MCF-7/DOX cells and its underlying molecular mechanism. Methods: The cytotoxic effects of C49 on MCF-7/DOX cells were evaluated by MTT assay using dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ting, Dong, Jingjing, Yuan, Xu, Wen, Haotian, Wu, Linguangjin, Liu, Jianwen, Sui, Hua, Deng, Wanli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076869/ https://www.ncbi.nlm.nih.gov/pubmed/33927626 http://dx.doi.org/10.3389/fphar.2021.653306

Ejemplares similares

Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin
por: Xue, Chaojun, et al.
Publicado: (2016)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2020)

Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox
por: Yao, Ling, et al.
Publicado: (2011)

Regulation of P-glycoprotein 1 and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones.
por: Davies, R., et al.
Publicado: (1996)

A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells
por: Wang, Liang, et al.
Publicado: (2016)

Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux
por: Pan, Guixiang, et al.
Publicado: (2016)

Evaluation of the Anticancer Activity of Calcium Ions Introduced into Human Breast Adenocarcinoma Cells MCF-7/WT and MCF-7/DOX by Electroporation
por: Bieżuńska-Kusiak, Katarzyna, et al.
Publicado: (2023)

Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells
por: Liu, Ming, et al.
Publicado: (2016)

Screening Multidrug Resistance Reversal Agents in Traditional Chinese Medicines by Efflux Kinetics of D-Luciferin in MCF-7/DOX(Fluc) Cells
por: Zhao, Yue, et al.
Publicado: (2023)

Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-κB-Independent Mechanism
por: Zhong, Zhang-Feng, et al.
Publicado: (2017)

Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990
por: Chen, Bin, et al.
Publicado: (2022)

Corrigendum: Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-κB-Independent Mechanism
por: Zhong, Zhang-Feng, et al.
Publicado: (2017)

A leukotriene B(4) receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells
por: Kim, H, et al.
Publicado: (2013)

LC-MS/MS Proteomic Study of MCF-7 Cell Treated with Dox and Dox-Loaded Calcium Carbonate Nanoparticles Revealed Changes in Proteins Related to Glycolysis, Actin Signalling, and Energy Metabolism
por: Ahmed, Hamidu, et al.
Publicado: (2021)

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models
por: Li, Ying, et al.
Publicado: (2017)

Curcumin increases the sensitivity of K562/DOX cells to doxorubicin by targeting S100 calcium-binding protein A8 and P-glycoprotein
por: Yang, Liu, et al.
Publicado: (2020)

CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
por: Liu, Qiqian, et al.
Publicado: (2020)

Dual-Targeted Self-Assembled DNA Hydrogels Decorated With Multivalent Aptamers Loaded With DOX for Anticancer Therapy
por: Jin, Fangfang, et al.
Publicado: (2022)

Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride
por: Chen, Yuan-Yuan, et al.
Publicado: (2016)

Correction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
por: Liu, Qiqian, et al.
Publicado: (2022)

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
por: Igarashi, Kentaro, et al.
Publicado: (2018)

Surface Stiffness Has No Impact on MCF-7 Sensitivity to Doxorubicin
por: Šimoliūnas, Egidijus, et al.
Publicado: (2023)

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance
por: Chen, Zhenzhen, et al.
Publicado: (2023)

Trifluoperazine prevents FOXO1 nuclear excretion and reverses doxorubicin-resistance in the SHG44/DOX drug-resistant glioma cell line
por: Chen, Xiaozhong, et al.
Publicado: (2018)

Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
por: Srdic-Rajic, Tatjana, et al.
Publicado: (2017)

Dicoma anomala Enhances Phthalocyanine Mediated Photodynamic Therapy in MCF-7 Breast Cancer Cells
por: Chota, Alexander, et al.
Publicado: (2022)

Characterization of resistant MCF-7 breast cancer cells developed by repeated cycles of photodynamic therapy
por: Aniogo, Eric Chekwube, et al.
Publicado: (2022)

Ferruginol Restores SIRT1-PGC-1α-Mediated Mitochondrial Biogenesis and Fatty Acid Oxidation for the Treatment of DOX-Induced Cardiotoxicity
por: Li, Weili, et al.
Publicado: (2021)

Reversal of multidrug resistance by 5,5’-dimethoxylariciresinol-4-O-β-D-glucoside in doxorubicin-resistant human leukemia K562/DOX
por: Wang, Tian-Xiao, et al.
Publicado: (2013)

Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
por: Zhang, Shuhui, et al.
Publicado: (2020)

Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity
por: Das, Mahasweta, et al.
Publicado: (2017)

Mollification of Doxorubicin (DOX)-Mediated Cardiotoxicity Using Conjugated Chitosan Nanoparticles with Supplementation of Propionic Acid
por: Siva, Durairaj, et al.
Publicado: (2022)

Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells
por: Tan, Aik-Aun, et al.
Publicado: (2015)

Oxyresveratrol Modulates Genes Associated with Apoptosis, Cell Cycle Control and DNA Repair in MCF-7 Cells
por: Radapong, Sarayut, et al.
Publicado: (2021)

Trans-Chalcone Attenuates Pain and Inflammation in Experimental Acute Gout Arthritis in Mice
por: Staurengo-Ferrari, Larissa, et al.
Publicado: (2018)

Exploring the Therapeutic Potential of trans-Chalcone: Modulation of MicroRNAs Linked to Breast Cancer Progression in MCF-7 Cells
por: Komoto, Tatiana Takahasi, et al.
Publicado: (2023)

Combined effect of papuamine and doxorubicin in human breast cancer MCF-7 cells
por: KANNO, SYU-ICHI, et al.
Publicado: (2014)

Cholesterol Dependent Uptake and Interaction of Doxorubicin in MCF-7 Breast Cancer Cells
por: Weber, Petra, et al.
Publicado: (2013)

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j0qfu6d3uq1je2uk2htp169v9d